Adrenomedullin production is increased in colorectal adenocarcinomas; its relation to matrix metalloproteinase-9
► Gene expression and peptide concentration of adrenomedullin (AM) were highly expressed in colorectal cancer tissues. ► The level of preproAM mRNA was positively correlated with MMP-9, but not with VEGF-A. ► Immunoreactivity of AM was present in cancer cells, while MMP-9 localized in stroma cells s...
Saved in:
Published in | Peptides (New York, N.Y. : 1980) Vol. 32; no. 9; pp. 1825 - 1831 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
New York, NY
Elsevier Inc
01.09.2011
Elsevier |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | ► Gene expression and peptide concentration of adrenomedullin (AM) were highly expressed in colorectal cancer tissues. ► The level of preproAM mRNA was positively correlated with MMP-9, but not with VEGF-A. ► Immunoreactivity of AM was present in cancer cells, while MMP-9 localized in stroma cells surrounding the tumors.
Adrenomedullin (AM) is highly expressed in various cancer cell lines, suggesting a possible association with cancer growth. In the present study, we examined the expression and/or concentration of AM, its related peptide, adrenomedullin2/intermedin (AM2/IMD) and their receptors in human colorectal cancer and the surrounding normal tissue. In addition, we assessed the correlation between the expression of AM and AM2/IMD with that of vascular endothelial growth factor (VEGF)-A and matrix metalloproteinase (MMP)-9. Using a specific immunoradiometric assay, we found that AM concentrations were 2–11-fold higher in colorectal cancer tissues than in the surrounding normal tissues. Moreover, real-time quantitative RT-PCR showed that the expression levels of preproAM (+548%), preproAM2/IMD (+2674%), calcitonin receptor-like receptor (CLR) (+518%), receptor activity modifying protein (RAMP)2 (+281%), RAMP3 (+178%), VEGF-A (+277%) and MMP-9 (+864%) mRNAs were significantly higher in cancer tissues than in the surrounding normal tissues, and there was a positive correlation between the gene expressions of MMP-9 and preproAM (r=0.352; p=0.005), but not with preproAM2/IMD (r=0.041, p=0.406). Both AM and AM2/IMD immunoreactivity were detected mainly within cancer cells, whereas MMP-9 immunoreactivity was mostly seen in the surrounding stroma. These findings suggest that AM produced in colorectal tumors acts in concert with MMP-9 in the stroma to contribute to the pathogenesis of colorectal cancer. |
---|---|
Bibliography: | http://dx.doi.org/10.1016/j.peptides.2011.07.012 ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 ObjectType-Article-2 ObjectType-Feature-1 |
ISSN: | 0196-9781 1873-5169 |
DOI: | 10.1016/j.peptides.2011.07.012 |